Outset Medical's Q225 Earnings: Steady Growth & Cybersecurity Clearance

Outset Medical reported steady growth in Q2 2025, with a 5% increase in full-year revenue to $119.5 million. The company expanded gross margins, reduced cash burn, and narrowed losses, while also receiving FDA clearance for its next-gen Tablo.

Listen